Develops hormone therapy pharmaceutical products for women.
Jun 2026Revenue $3.27M/yrExpenses $7.22M/yr
No trendCash runway ≈ 1 months from Mar 2025
Figures by year
When will TherapeuticsMD be profitable?
Its figures don’t show a steady enough trend to project a date. In the 12 months to Jun 2026, revenue was $3.27M and expenses $7.22M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2025 | $3.02M | $7.41M | −$4.39M |
| Dec 2024 | $1.76M | $7.87M | −$6.11M |
| Dec 2023 | $1.30M | $9.82M | −$8.52M |
| Dec 2022 | $70.0M | $68.8M | $1.19M |
| Dec 2021 | $2.57M | $82.2M | −$79.6M |
| Dec 2020 | $64.9M | $220M | −$156M |
| Dec 2019 | $49.6M | $201M | −$151M |
| Dec 2018 | $16.1M | $146M | −$130M |
| Dec 2017 | $16.8M | $94.4M | −$77.6M |
| Dec 2016 | $19.4M | $110M | −$90.3M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.